Comparing GLP-1 Medications for Weight Loss: What the Clinical Evidence Shows
Approximately 10 million Americans were enrolled in GLP-1 receptor agonist treatment programs by 2025 – a figure that represents nearly a sevenfold increase in the proportion of overweight and obese adults receiving this class of medication compared to just a few years prior. As GLP-1 therapy has moved from specialist prescribing into primary care and […]
Comparing GLP-1 Medications for Weight Loss: What the Clinical Evidence Shows Read More »










